today EAO Madrid October 06, 2017

(cid:4) 3 Unsurprisingly, a very high im- plant survival rate for implants with the TiUnite surface was reported. We know now that TiUnite has a very good clinical record of maintained bone levels in the vast majority of cases. There are actually ﬁve differ- ent ten-year studies on TiUnite that demonstrated well-maintained bone levels. What does the meta-analysis tell us about rates of peri-implantitis with TiUnite implants? The publications that assessed biological complications revealed a low prevalence of peri-implantitis with TiUnite implants. This was not a big surprise either. The ﬁgures we have seen widely reported in the lit- erature are exaggerated. They say that any bone loss after the ﬁrst year is disease, which is, to put it mildly, incorrect. We see main- tained bone levels in this study and in other ten-year follow-up studies with TiUnite. If peri-implantitis is a disease—which is still under de- bate—it may affect 1 per cent of im- plants after ten years. If by “dis- ease” we mean bone loss that threat- ens the survival of the implant, it is in the order of 1 per cent. Nobel Biocare’s implant systems are not the only ones that have shown good results with respect to peri-implantitis, but if I were to choose an implant today I would look at the documented research, which is so much better with Nobel Biocare. The TiUnite implant sur- face is backed by more ﬁve- and ten- year studies than any other implant surfaces from its competitors. When it comes to supporting evidence, Nobel Biocare implants have the ad- vantage. AD register for FREE – education everywhere and anytime – live and interactive webinars – more than 1,000 archived courses – a focused discussion forum – free membership – no travel costs – no time away from the practice – interaction with colleagues and experts across the globe – a growing database of scientific articles and case reports – ADA CERP-recognized credit administration www. DTStudyClub.com Join the largest educational network in dentistry! ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providersof continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. 4 26th EAO Annual Scientiﬁc Meeting news How can the ﬁndings of this meta- analysis be used to optimise clini- cal outcomes? I think that we have to strive for continuous improvement. If one had 19 per cent mortality with appendi- citis cases in the 1800s, one was bet- ter than the average doctor. Nowa- days, such a high mortality rate would lead to one losing one’s li- cence. We have new techniques. It is a similar story with dental implants. We have to constantly challenge what we think of now as the ulti- mate implant solution in order to have even better solutions for pa- tients in future. It is a continuing mission and I know that Nobel Biocare is involved (cid:24)Photograph shows osseoconductive bone for- mation. Human histology six months after implant insertion with bone anchored in the TiUnite pores. (© Dr Peter Schüpbach) in a number of studies with the goal of making further improvements. I think this is exactly the right ap- proach because the ideal situation is that we have 100 per cent sur- vival and success rates after ten years. We are not there yet, but that is the goal. You have been involved with re- search evaluating Nobel Biocare implants for many years. Have the ﬁndings of your analysis changed your perception of the TiUnite sur- face? While the meta-analysis is an- other validation of TiUnite’s efﬁ- cacy, its high performance has been conﬁrmed in other types of clinical studies. Meta-analysis offers high- quality insight, but one needs a wide range of supporting evidence. TiUnite is backed not just by pro- spective studies, as we examined, but by retrospective research and other study types as well. The state- ments we make about TiUnite im- plants today can therefore be made with great conﬁdence. I saw TiUnite being launched in 2000. I believed in it then and now I know that my beliefs were correct. It is a superb implant surface. Thank you very much for this inter- view. (cid:26) Reference : 1. Karl, M & Albrektsson, T, “Clinical performance of dental implants with a moderately rough (TiUnite) surface: A meta-analysis of prospec- tive clinical studies”, International Journal of Oral and Maxillofacial Implants, 32/4 (Jul/Aug 2017), 717–34. doi: 10.11607/jomi.5699. More information about the TiUnite surface and its supporting clinical evidence can be found at nobelbiocare.com/tiunite.

today EAO Madrid October 06, 2017

Pages Overview